|
Additional information provided in e.1., h.6.And h.11.A sample was not received at the investigation site for evaluation for the report; therefore, the condition of the product could not be verified.A review of the device history record traceable to the reported lot number, indicates that the reported product was processed and released according to the reported product¿s acceptance criteria.The video was reviewed by the manufacturing site.The video shows the phacoemulsification tip cutting and then stops cutting.The surgeon removes the phacoemulsification tip from the eye and appears to be broken at the aspiration bypass hole.The reported issue is confirmed from the video review.The video review confirms the broken phacoemulsification tip; however, a sample was not received at the manufacturing site and the device history record review of the lot number provided indicated the product was processed and released according to the product¿s acceptable criteria, therefore; the root cause for the customer complaint issue cannot be determined.The exact root cause for this complaint is unknown, therefore, specific action with regards to this complaint cannot be taken.All phacoemulsification tips are 100% visually inspected by trained operators using 30x magnification during the manufacturing process.Complaints are reviewed and monitored at regular intervals for any significant adverse trends.No adverse trends have been observed associated with the reported product and event.No additional action is required at this time.The manufacturer internal reference number is: (b)(4).
|